A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort.
Saved in:
| Title: | A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort. |
|---|---|
| Authors: | Sreenath, Nihanthy D.1 (AUTHOR) nihanthyds@gmail.com, Pandalanghat, Suresh2 (AUTHOR), Kapoor, Amul2 (AUTHOR), Govind, Rajath2 (AUTHOR), Kaushik, M. R.3 (AUTHOR), Nair, Rajesh4 (AUTHOR), Bhuva, Dipen5 (AUTHOR), Rathore, Anvesh2 (AUTHOR), Kumar, Manish2 (AUTHOR), Mulajker, Deepak2 (AUTHOR) |
| Source: | BMC Cancer. 8/18/2025, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-14270-1 |
